跳至主要内容
临床试验/CTRI/2018/11/016425
CTRI/2018/11/016425尚未招募3 期

A Randomized Controlled Trial comparing the efficacy and safety of Olanzapine and Haloperidol , and its assessment with homocysteine in schizophrenia patients - OLHALOHOMSCHIZO

VENKATA AKSHEENA VARAHI VEDAM0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • A newly diagnosed schizophrenia acording to DSM-V criteria

排除标准

  • Known allergic to Olanzapine or Haloperidol
  • -Unstable patients unable to give consent for the study
  • -Liver failure and kidney failure patients
  • -Pregnant women and lactating mothers
  • -Subject who is currently enrolled in another investigational drug study

研究者

发起方
VENKATA AKSHEENA VARAHI VEDAM

相似试验